Mechanisms of host leukocyte-mediated Toxoplasma dissemination in its host
宿主白细胞介导的弓形虫在宿主体内传播的机制
基本信息
- 批准号:10623334
- 负责人:
- 金额:$ 46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-17 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:2-tyrosineAcquired Immunodeficiency SyndromeActinsAdaptor Signaling ProteinAdhesivesAffectAnimal ModelAnimalsAttenuated VaccinesBar CodesBehaviorBindingBiochemicalBiochemistryBiological AssayBioluminescenceBlindnessBrainCRISPR/Cas technologyCell-Matrix JunctionCellsCellular biologyCessation of lifeCo-ImmunoprecipitationsComplexCytoskeletonCytosolDataDefectDendritic CellsDevelopmentDiseaseDisseminated Malignant NeoplasmDistantEquus caballusExhibitsFetusFoundationsGenesHIVHuman bodyImageImmuneImmune systemImmunocompromised HostIn VitroIndividualInfantInfectionInterventionKnowledgeLeukocytesLifeLuciferasesMeasuresMediatingMesenchymalMolecularMothersMusNCK adaptor protein 1NR0B2 geneNamesOrganPTPN11 genePTPN6 geneParasitesPathologyPathway interactionsPatientsPeptidesPersonsPhosphoric Monoester HydrolasesPolymersPopulationProcessProline-Rich DomainProtein KinaseProtein Tyrosine PhosphataseProteinsRecombinantsRegulationResearchRouteShuttle VectorsSiteStructureTestingTherapeutic InterventionTimeTissuesToxoplasmaToxoplasma gondiiToxoplasmosisTransplant RecipientsTyrosine PhosphorylationVaccinesWorkacute infectioncancer cellcell motilityfoodborneimmunosuppressedin vivoinnovationinsightloss of functionmigrationmutantnovelnovel therapeuticsparasite invasionpathogenpolymerizationpreventprotein protein interactionprotein purificationreceptorresponserhotransmission process
项目摘要
The intracellular parasite Toxoplasma gondii causes life-threatening disease in immunosuppressed or
transplant patients. Its pathology mainly relies on the dissemination of the parasite from the site of infection to
various essential organs, such as the brain, where it causes tissue destruction. T. gondii often uses a Trojan
Horse mechanism to facilitate its dissemination, during which it hijacks the host cell migration machinery to co-
opt host leukocytes as shuttling vectors. Exactly how T. gondii does so, however, is largely unknown. We
recently identified a novel T. gondii protein important for its dissemination, which we named TgWIP. We found
that upon invasion the parasite secreted TgWIP into the host cell cytosol, where TgWIP stimulated dendritic
cells to become hyper-migratory and undergo a mesenchymal to amoeboid transition (MAT). The process was
associated with a dramatic rearrangement of the actin cytoskeleton. The overall objective of this application is
to determine the molecular mechanisms by which TgWIP mediates T. gondii dissemination in the host. Our
central hypothesis is that TgWIP promotes dissemination by modulating leukocyte actin dynamics. This
hypothesis was formulated based on our preliminary data showing that TgWIP directly interacts with several
central regulators of the actin cytoskeleton involved in cell migration, including the WAVE regulatory complex
(WRC), the SH2-SH3 adaptor proteins Nck and Grb2, and the SHP1/2 tyrosine phosphatases. We will test our
hypothesis by pursuing two aims: 1) determine how TgWIP interacts with various actin regulators to modulate
host actin dynamics in vitro, and 2) determine how TgWIP enhances host leukocyte motility to facilitate
dissemination in vivo. Specifically, our team will combine biochemistry, cell biology, and animal models to
determine (i) how TgWIP directly interacts with the WRC, Nck, Grb2, and SHP1/2, and how the interactions
influence actin polymerization in vitro; (ii) how these interactions alter the migrative behaviors of primary
dendritic cells; and (iii) how disruption of these interactions influences in vivo dissemination of T. gondii in mice.
Our proposed research is innovative because it will unravel a novel mechanism by which TgWIP, as a newly
identified parasite effector unique to T. gondii, coordinates several distinct host actin regulators to reroute
leucocyte migration and facilitate T. gondii dissemination. Our work is significant because understanding the
molecular and biochemical mechanisms underlying T. gondii dissemination will lay the foundation for the
development of novel interventions that can directly target these mechanisms and block T. gondii
dissemination after acute infection or reactivation in AIDS or transplant patients or from the mother to the fetus.
This knowledge will be also important for the development of a safe, non-transmissible live vaccine that can
prevent T. gondii transmission from animals. Furthermore, by understanding how TgWIP promotes MAT in
infected DCs, our work will provide valuable insights into how other cells, such as metastatic cancer cells and
leukocytes, may use a similar mechanism to undergo MAT in response to diverse environmental conditions.
细胞内寄生虫弓形虫弓形虫在免疫抑制或
移植患者。它的病理主要依赖于从感染部位传播寄生虫
各种必需器官,例如大脑,会导致组织破坏。 T. Gondii经常使用特洛伊木马
马匹机制促进其传播,在此期间,它劫持了宿主细胞迁移机制
选择主机白细胞作为穿梭媒介。然而,T。Gondii的目的是在很大程度上尚不清楚。我们
最近确定了一种新颖的gondii蛋白对于其传播很重要,我们将其命名为TGWIP。我们发现
入侵后,寄生虫将TGWIP分泌到宿主细胞胞质中,TGWIP刺激了树突状
细胞成为过度迁移的,并经历间充质到变形虫过渡(MAT)。该过程是
与肌动蛋白细胞骨架的戏剧性重排有关。该应用程序的总体目标是
为了确定TGWIP介导宿主中T. gondii传播的分子机制。我们的
中心假设是TGWIP通过调节白细胞肌动蛋白动力学来促进传播。这
根据我们的初步数据提出了假设,表明TGWIP直接与几种相互作用
与细胞迁移有关的肌动蛋白细胞骨架的中心调节剂,包括波调节复合物
(WRC),SH2-SH3适配器蛋白NCK和GRB2,以及SHP1/2酪氨酸磷酸酶。我们将测试我们的
通过追求两个目标假设:1)确定TGWIP如何与各种肌动蛋白调节剂相互作用以调节
体外宿主肌动蛋白动力学,2)确定TGWIP如何增强宿主白细胞运动以促进
体内传播。具体而言,我们的团队将将生物化学,细胞生物学和动物模型结合起来
确定(i)TGWIP如何直接与WRC,NCK,GRB2和SHP1/2相互作用,以及如何相互作用
在体外影响肌动蛋白聚合; (ii)这些相互作用如何改变主要的迁移行为
树突状细胞; (iii)这些相互作用的破坏如何影响小鼠gondii的体内传播。
我们提出的研究具有创新性,因为它将揭示出一种新型机制
鉴定出T. gondii独有的寄生虫效应子,协调了几个不同的宿主肌动蛋白调节剂以重新布局
白细胞迁移并促进了弓形虫的传播。我们的工作很重要,因为了解
T. gondii传播基础的分子和生化机制将为
开发新的干预措施,这些干预措施可以直接瞄准这些机制并阻止T. gondii
急性感染或艾滋病患者或从母亲到胎儿的急性感染或重新激活后的传播。
这些知识对于开发安全的,不可允许的活疫苗也将很重要
防止弓形虫从动物中传播。此外,通过了解TGWIP如何促进MAT
感染的DC,我们的工作将为其他细胞(例如转移性癌细胞和)如何提供宝贵的见解。
白细胞可能会使用类似的机制来响应各种环境条件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Baoyu Chen其他文献
Baoyu Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Baoyu Chen', 18)}}的其他基金
Signal Integration from Membranes to the Actin Cytoskeleton
从膜到肌动蛋白细胞骨架的信号整合
- 批准号:
10217192 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
Signal Integration from Membranes to the Actin Cytoskeleton
从膜到肌动蛋白细胞骨架的信号整合
- 批准号:
10470730 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
Signal Integration from Membranes to the Actin Cytoskeleton
从膜到肌动蛋白细胞骨架的信号整合
- 批准号:
9751336 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
Signal Integration from Membranes to the Actin Cytoskeleton
从膜到肌动蛋白细胞骨架的信号整合
- 批准号:
10623679 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
Signal Integration from Membranes to the Actin Cytoskeleton
从膜到肌动蛋白细胞骨架的信号整合
- 批准号:
9982353 - 财政年份:2018
- 资助金额:
$ 46万 - 项目类别:
相似海外基金
Develop and Assess mRNA Lipid Nanoparticle Vaccines Against Cryptococcosis
开发并评估针对隐球菌病的 mRNA 脂质纳米颗粒疫苗
- 批准号:
10616313 - 财政年份:2023
- 资助金额:
$ 46万 - 项目类别:
Mechanisms of KSHV-induced endothelial cell loss of contact inhibition of proliferation
KSHV诱导内皮细胞失去接触抑制增殖的机制
- 批准号:
10762813 - 财政年份:2023
- 资助金额:
$ 46万 - 项目类别:
Analysis of human retrovirus particle assembly sites
人逆转录病毒颗粒组装位点分析
- 批准号:
10326739 - 财政年份:2021
- 资助金额:
$ 46万 - 项目类别:
Dissecting Hem-1 functions in B lymphocyte Development and Primary Immunodeficiency Disease
剖析 Hem-1 在 B 淋巴细胞发育和原发性免疫缺陷病中的功能
- 批准号:
10385848 - 财政年份:2021
- 资助金额:
$ 46万 - 项目类别: